These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 31308191)

  • 1. First study of safety and tolerability of 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy in patients with alcohol use disorder: preliminary data on the first four participants.
    Sessa B; Sakal C; O'Brien S; Nutt D
    BMJ Case Rep; 2019 Jul; 12(7):. PubMed ID: 31308191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First study of safety and tolerability of 3,4-methylenedioxymethamphetamine-assisted psychotherapy in patients with alcohol use disorder.
    Sessa B; Higbed L; O'Brien S; Durant C; Sakal C; Titheradge D; Williams TM; Rose-Morris A; Brew-Girard E; Burrows S; Wiseman C; Wilson S; Rickard J; Nutt DJ
    J Psychopharmacol; 2021 Apr; 35(4):375-383. PubMed ID: 33601929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3,4-Methylenedioxymethamphetamine-assisted psychotherapy for treatment of chronic posttraumatic stress disorder: A randomized phase 2 controlled trial.
    Ot'alora G M; Grigsby J; Poulter B; Van Derveer JW; Giron SG; Jerome L; Feduccia AA; Hamilton S; Yazar-Klosinski B; Emerson A; Mithoefer MC; Doblin R
    J Psychopharmacol; 2018 Dec; 32(12):1295-1307. PubMed ID: 30371148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in military veterans, firefighters, and police officers: a randomised, double-blind, dose-response, phase 2 clinical trial.
    Mithoefer MC; Mithoefer AT; Feduccia AA; Jerome L; Wagner M; Wymer J; Holland J; Hamilton S; Yazar-Klosinski B; Emerson A; Doblin R
    Lancet Psychiatry; 2018 Jun; 5(6):486-497. PubMed ID: 29728331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction in social anxiety after MDMA-assisted psychotherapy with autistic adults: a randomized, double-blind, placebo-controlled pilot study.
    Danforth AL; Grob CS; Struble C; Feduccia AA; Walker N; Jerome L; Yazar-Klosinski B; Emerson A
    Psychopharmacology (Berl); 2018 Nov; 235(11):3137-3148. PubMed ID: 30196397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term follow-up outcomes of MDMA-assisted psychotherapy for treatment of PTSD: a longitudinal pooled analysis of six phase 2 trials.
    Jerome L; Feduccia AA; Wang JB; Hamilton S; Yazar-Klosinski B; Emerson A; Mithoefer MC; Doblin R
    Psychopharmacology (Berl); 2020 Aug; 237(8):2485-2497. PubMed ID: 32500209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of MDMA-assisted psychotherapy to non-assisted psychotherapy in treatment-resistant PTSD: A systematic review and meta-analysis.
    Illingworth BJ; Lewis DJ; Lambarth AT; Stocking K; Duffy JM; Jelen LA; Rucker JJ
    J Psychopharmacol; 2021 May; 35(5):501-511. PubMed ID: 33345689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for posttraumatic stress disorder: A systematic review and meta-analysis.
    Bahji A; Forsyth A; Groll D; Hawken ER
    Prog Neuropsychopharmacol Biol Psychiatry; 2020 Jan; 96():109735. PubMed ID: 31437480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized, controlled pilot study of MDMA (± 3,4-Methylenedioxymethamphetamine)-assisted psychotherapy for treatment of resistant, chronic Post-Traumatic Stress Disorder (PTSD).
    Oehen P; Traber R; Widmer V; Schnyder U
    J Psychopharmacol; 2013 Jan; 27(1):40-52. PubMed ID: 23118021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MDMA-assisted psychotherapy for treatment of PTSD: study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomized controlled trials.
    Mithoefer MC; Feduccia AA; Jerome L; Mithoefer A; Wagner M; Walsh Z; Hamilton S; Yazar-Klosinski B; Emerson A; Doblin R
    Psychopharmacology (Berl); 2019 Sep; 236(9):2735-2745. PubMed ID: 31065731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MDMA-assisted psychotherapy for treatment of anxiety and other psychological distress related to life-threatening illnesses: a randomized pilot study.
    Wolfson PE; Andries J; Feduccia AA; Jerome L; Wang JB; Williams E; Carlin SC; Sola E; Hamilton S; Yazar-Klosinski B; Emerson A; Mithoefer MC; Doblin R
    Sci Rep; 2020 Nov; 10(1):20442. PubMed ID: 33235285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The safety and efficacy of {+/-}3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study.
    Mithoefer MC; Wagner MT; Mithoefer AT; Jerome L; Doblin R
    J Psychopharmacol; 2011 Apr; 25(4):439-52. PubMed ID: 20643699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discontinuation of medications classified as reuptake inhibitors affects treatment response of MDMA-assisted psychotherapy.
    Feduccia AA; Jerome L; Mithoefer MC; Holland J
    Psychopharmacology (Berl); 2021 Feb; 238(2):581-588. PubMed ID: 33221932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute subjective effects in LSD- and MDMA-assisted psychotherapy.
    Schmid Y; Gasser P; Oehen P; Liechti ME
    J Psychopharmacol; 2021 Apr; 35(4):362-374. PubMed ID: 33853422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study.
    Mitchell JM; Bogenschutz M; Lilienstein A; Harrison C; Kleiman S; Parker-Guilbert K; Ot'alora G M; Garas W; Paleos C; Gorman I; Nicholas C; Mithoefer M; Carlin S; Poulter B; Mithoefer A; Quevedo S; Wells G; Klaire SS; van der Kolk B; Tzarfaty K; Amiaz R; Worthy R; Shannon S; Woolley JD; Marta C; Gelfand Y; Hapke E; Amar S; Wallach Y; Brown R; Hamilton S; Wang JB; Coker A; Matthews R; de Boer A; Yazar-Klosinski B; Emerson A; Doblin R
    Nat Med; 2021 Jun; 27(6):1025-1033. PubMed ID: 33972795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Why MDMA therapy for alcohol use disorder? And why now?
    Sessa B
    Neuropharmacology; 2018 Nov; 142():83-88. PubMed ID: 29126911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MDMA-Assisted Psychotherapy for Treatment of Posttraumatic Stress Disorder: A Systematic Review With Meta-Analysis.
    Smith KW; Sicignano DJ; Hernandez AV; White CM
    J Clin Pharmacol; 2022 Apr; 62(4):463-471. PubMed ID: 34708874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MDMA-assisted therapy for posttraumatic stress disorder: A pooled analysis of ethnoracial differences in efficacy and safety from two Phase 2 open-label lead-in trials and a Phase 3 randomized, blinded placebo-controlled trial.
    Ching TH; Williams MT; Wang JB; Jerome L; Yazar-Klosinski B; Emerson A; Doblin R
    J Psychopharmacol; 2022 Aug; 36(8):974-986. PubMed ID: 35727042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic effect of increased openness: Investigating mechanism of action in MDMA-assisted psychotherapy.
    Wagner MT; Mithoefer MC; Mithoefer AT; MacAulay RK; Jerome L; Yazar-Klosinski B; Doblin R
    J Psychopharmacol; 2017 Aug; 31(8):967-974. PubMed ID: 28635375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MDMA-assisted psychotherapy using low doses in a small sample of women with chronic posttraumatic stress disorder.
    Bouso JC; Doblin R; Farré M; Alcázar MA; Gómez-Jarabo G
    J Psychoactive Drugs; 2008 Sep; 40(3):225-36. PubMed ID: 19004414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.